Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches.
about
How do chemotherapeutic agents damage the ovary?Effects of Bushen Tianjing Recipe in a rat model of tripterygium glycoside-induced premature ovarian failureAmniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy.Synthesis and functional analysis of novel bivalent estrogens.Fertility preservation in women with cancer.Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist.Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatinChemotherapy-Induced Amenorrhea - An UpdateExosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.Androgen therapy and atherosclerotic cardiovascular disease.Effects of sex hormone levels on aortic vascular reactivity and variables associated with the metabolic syndrome in sucrose-fed female rats.
P2860
Q28267696-168551FC-D427-4F5F-857B-5EE075AE1098Q33594483-06DF205F-210B-4D6C-9142-8C771B84748AQ34149813-3D6E715D-D81F-4A8E-952B-CEE0DBEEC286Q34170273-5BD8BBE2-7694-4449-9391-053FD6F303C6Q34729392-F29D3BF3-9E2F-4F67-B0AF-A39D866A8EA7Q34779992-7D3BC04B-290A-4D48-A853-AF2C128F0DBDQ34905992-6C5CEDE4-C501-4245-9DC1-55B8D5898FCAQ36295133-5D2E5E0E-872A-4F26-8F20-C48E286E8229Q36691028-2D19AB6A-FA4D-4D4F-97F6-79707FD65C30Q36766910-B526DD05-D4FA-471A-82B1-5741ECB7D703Q46640258-3397E38B-D6CE-4850-8824-7AE5F4C82157
P2860
Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiovascular risk in women: ...... or new therapeutic approaches.
@ast
Cardiovascular risk in women: ...... or new therapeutic approaches.
@en
type
label
Cardiovascular risk in women: ...... or new therapeutic approaches.
@ast
Cardiovascular risk in women: ...... or new therapeutic approaches.
@en
prefLabel
Cardiovascular risk in women: ...... or new therapeutic approaches.
@ast
Cardiovascular risk in women: ...... or new therapeutic approaches.
@en
P2860
P356
P1476
Cardiovascular risk in women: ...... or new therapeutic approaches.
@en
P2093
David Newby
Helen Jeanes
P2860
P304
P356
10.1517/14656566.8.3.279
P407
P577
2007-02-01T00:00:00Z